Evidence map›Paper›PMID 33634266›Full record

ArticleCritical care explorations2021

First and Second Waves of Coronavirus Disease 2019 in Madrid, Spain: Clinical Characteristics and Hematological Risk Factors Associated With Critical/Fatal Illness.

Irene Mollinedo-Gajate, Felipe Villar-Álvarez, María de Los Ángeles Zambrano-Chacón, Laura Núñez-García, Laura de la Dueña-Muñoz, Carlos López-Chang, Miguel Górgolas, Alfonso Cabello, Olga Sánchez-Pernaute, Fredeswinda Romero-Bueno and 4 more

Open access · goldAbstract read
In one paragraph

Article in Critical care explorations, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Irene Mollinedo-GajateLaboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas Margarita Salas, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Felipe Villar-ÁlvarezDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
María de Los Ángeles Zambrano-ChacónDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
Laura Núñez-GarcíaDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
Laura de la Dueña-MuñozDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
Carlos López-ChangDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
Miguel GórgolasDivision of Infectious Diseases, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Alfonso CabelloDivision of Infectious Diseases, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Olga Sánchez-PernauteDepartment of Rheumatology, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Fredeswinda Romero-BuenoDepartment of Rheumatology, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Álvaro AceñaDepartment of Cardiology, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Nicolás González-MangadoDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
Germán Peces-BarbaDepartment of Pulmonology, Hospital Universitario Fundación Jiménez Díaz, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
Faustino MollinedoLaboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas Margarita Salas, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Centro de Investigaciones Biológicas Margarita Salas · ESHospital Universitario Fundación Jiménez Díaz · ESImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aims to determine similarities and differences in clinical characteristics between the patients from two waves of severe acute respiratory syndrome coronavirus-2 infection at the time of hospital admission, as well as to identify risk biomarkers of coronavirus disease 2019 severity.

designRetrospective observational study.

settingA single tertiary-care center in Madrid. PATIENTS: Coronavirus disease 2019 adult patients admitted to hospital from March 4, 2020, to March 25, 2020 (first infection wave), and during July 18, 2020, and August 20, 2020 (second infection wave).

interventionsTreatment with a hospital-approved drug cocktail during hospitalization. MEASUREMENTS AND MAIN

resultsDemographic, clinical, and laboratory data were compared between the patients with moderate and critical/fatal illness across both infection waves. The median age of patients with critical/fatal coronavirus disease 2019 was 67.5 years (interquartile range, 56.75-78.25 yr; 64.5% male) in the first wave and 59.0 years (interquartile range, 48.25-80.50 yr; 70.8% male) in the second wave. Hypertension and dyslipidemia were major comorbidities in both waves. Body mass index over 25 and presence of bilateral pneumonia were common findings. Univariate logistic regression analyses revealed an association of a number of blood parameters with the subsequent illness progression and severity in both waves. However, some remarkable differences were detected between both waves that prevented an accurate extrapolation of prediction models from the first wave into the second wave. Interleukin-6 and d-dimer concentrations at the time of hospital admission were remarkably higher in patients who developed a critical/fatal condition only during the first wave (

conclusionsMost parameters analyzed behaved similarly in the two waves of coronavirus disease 2019. However, univariate logistic regression conducted in both waves revealed differences in some parameters associated with poor prognosis in wave 1 that were not found in wave 2, which may reflect a different disease stage of patients on arrival to hospital. The six-biomarker predictive signature reported here constitutes a helpful tool to classify patient's prognosis on arrival to hospital.

Indexed as

blood biomarkerscoronavirus disease 2019critical/fatal illnessfirst and second wave of infectionprognosisrisk factorssevere acute respiratory syndrome coronavirus 2

Identifiers

PMID33634266
PMCPMC7901790
OpenAlexW3130658084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.